CLINICAL_TRIALS
trial_result
· 2014-06-18
Clinical Trial Update: A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial of ramucirumab in metastatic renal cell carcinoma completed; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2014-06-18